Literature DB >> 3697961

Enhancing effects of carbon tetrachloride in mouse hepatocarcinogenesis.

T A Dragani, G Manenti, G Della Porta.   

Abstract

The enhancing effects of 4 or 8 necrogenic doses of carbon tetrachloride (CCl4) on hepatocarcinogenesis were studied in female B6C3F1 mice previously treated with a single dose of N-nitroso-N-diethylamine (NDEA) at 7 days of age. The CCl4 treatments were given every other week and started either after weaning or at 18-26 weeks of age, and the animals were observed until 36 weeks of age. The number and size of hepatocellular nodules were then scored and analysed. Hepatocellular nodules were not observed in mice receiving either 4 or 8 CCl4 treatments without NDEA initiation. Both 4 and 8 CCl4 treatments promoted NDEA-initiated hepatocarcinogenesis, increasing nodule size but not nodule frequency. Eight CCl4 doses were more effective than 4 and gave the greatest increase in nodule size when administered from 18 to 32 weeks of age. In an additional experiment, 3 mice bearing hepatocellular nodules induced by a single infantile NDEA treatment were administered CCl4 once and killed 52 h later. Nine neoplastic nodules were examined and found to be resistant to the CCl4 induced necrosis, although cells in the nodules were actively dividing at the same rate as in the regenerating surrounding normal liver parenchyma. The ability of a few necrogenic CCl4 doses to enhance hepatocarcinogenesis may be related to a differential cytotoxicity on neoplastic and normal hepatocytes and to a similar mitogenic stimulus on both cell types.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3697961     DOI: 10.1016/0304-3835(86)90008-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.

Authors:  Takeki Uehara; Igor P Pogribny; Ivan Rusyn
Journal:  Curr Protoc Pharmacol       Date:  2014-09-02

2.  Radiomodulatory effect of liposome encapsulated AK-2123 on tumor in mice exposed to hepatocarcinogen.

Authors:  Anis Alam; Chowphi Chen Rapthap; Laishram Indira Singha; R N Sharan; Vinod Singh
Journal:  Mol Cell Biochem       Date:  2005-03       Impact factor: 3.396

3.  Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis.

Authors:  Takeki Uehara; Garrett R Ainslie; Kristi Kutanzi; Igor P Pogribny; Levan Muskhelishvili; Takeshi Izawa; Jyoji Yamate; Oksana Kosyk; Svitlana Shymonyak; Blair U Bradford; Gary A Boorman; Ramon Bataller; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2013-01-03       Impact factor: 4.849

4.  Biological Basis of Differential Susceptibility to Hepatocarcinogenesis among Mouse Strains.

Authors:  Robert R Maronpot
Journal:  J Toxicol Pathol       Date:  2009-04-06       Impact factor: 1.628

5.  Effects of Fas-mediated liver cell apoptosis on diethylnitrosamine-induced hepatocarcinogenesis in mice.

Authors:  A Hara; N Yoshimi; Y Yamada; K Matsunaga; K Kawabata; S Sugie; H Mori
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

6.  Enhanced liver metastatic potential of alpha-fetoprotein-producing human gastric carcinoma after carbon tetrachloride-induced liver damage in nude mice.

Authors:  H Sawada; K Nakatani; N Miyagi; T Nishiwada; A Watanabe; T Okumura; Y Yamada; M Tsutsumi; D Nakae; H Nakano
Journal:  Jpn J Cancer Res       Date:  1989-04

7.  The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.

Authors:  Takeki Uehara; Igor P Pogribny; Ivan Rusyn
Journal:  Curr Protoc       Date:  2021-08

Review 8.  Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis.

Authors:  G M Ledda-Columbano; P Coni; G Simbula; I Zedda; A Columbano
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

9.  Different effects of regenerative and direct mitogenic stimuli on the growth of initiated cells in the resistant hepatocyte model.

Authors:  P Coni; G Pichiri-Coni; M Curto; G Simbula; L Giacomini; D S Sarma; G M Ledda-Columbano; A Columbano
Journal:  Jpn J Cancer Res       Date:  1993-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.